BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 5:28:00 PM | Browse: 979 | Download: 832
Publication Name World Journal of Clinical Oncology
Manuscript ID 8348
Country United States
Received
2013-12-26 13:53
Peer-Review Started
2013-12-26 15:14
To Make the First Decision
2014-03-12 17:05
Return for Revision
2014-03-21 20:23
Revised
2014-04-21 23:09
Second Decision
2014-05-16 17:27
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-05-16 17:48
Articles in Press
2014-05-23 09:09
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-07-24 14:19
Publish the Manuscript Online
2014-08-01 16:16
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Clinical and scientific impact of human papillomavirus on head and neck cancer
Manuscript Source Invited Manuscript
All Author List Jeffrey M Friedman, Mark J Stavas and Anthony J Cmelak
Funding Agency and Grant Number
Corresponding Author Anthony J Cmelak, MD, Professor of Medicine, Department of Radiation Oncology, Vanderbilt University Medical Center, Preston Research Building, B-1003, Nashville, TN 37232-5671, United States. anthony.cmelak@vanderbilt.edu
Key Words Human papilloma virus; Head and neck cancer; Squamous cell carcinoma; Chemotherapy; Radiation; Molecular biology
Core Tip Head and neck squamous cell carcinoma (HNSCC) is the fifth most common cancer, and historically, in the developed world, was associated with tobacco and alcohol. However, beginning in 1983, investigators have found a growing proportion of HNSCC patients with human papillomavirus-positive (HPV) tumors who neither drank nor used tobacco. HPV has shifted the epidemiology and prognosis of HNSCC and HPV status is the strongest positive prognostic marker in patients with oropharyngeal SCC. This review will highlight the epidemiological, clinical and molecular discoveries surrounding HPV-related HNSCC over the recent decades and how these findings will guide future treatment approaches.
Publish Date 2014-08-01 16:16
Citation Friedman JM, Stavas MJ, Cmelak AJ. Clinical and scientific impact of human papillomavirus on head and neck cancer. World J Clin Oncol 2014; 5(4): 781-791
URL http://www.wjgnet.com/2218-4333/full/v5/i4/781.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i4.781
Full Article (PDF) WJCO-5-781.pdf
Full Article (Word) WJCO-5-781.doc
Manuscript File 8348-Review.docx
Answering Reviewers 8348-Answering reviewers.pdf
Copyright License Agreement 8348-Copyright assignment.pdf
Peer-review Report 8348-Peer review(s).pdf
Scientific Editor Work List 8348-Scientific editor work list.pdf